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Abstract
Background: HIV-responsive expression vectors are all based on the HIV promoter, the long
terminal repeat (LTR). While responsive to an early HIV protein, Tat, the LTR is also responsive
to cellular activation states and to the local chromatin activity where the integration has occurred.
This can result in high HIV-independent activity, and has restricted the use of LTR-based reporter
vectors to cloned cells, where aberrantly high expressing (HIV-negative) cells can be eliminated.
Enhancements in specificity would increase opportunities for expression vector use in detection of
HIV as well as in experimental gene expression in HIV-infected cells.
Results: We have constructed an expression vector that possesses, in addition to the Tat-
responsive LTR, numerous HIV DNA sequences that include the Rev-response element and HIV
splicing sites that are efficiently used in human cells. It also contains a reading frame that is removed
by cellular splicing activity in the absence of HIV Rev. The vector was incorporated into a lentiviral
reporter virus, permitting detection of replicating HIV in living cell populations. The activity of the
vector was measured by expression of green fluorescence protein (GFP) reporter and by PCR of
reporter transcript following HIV infection. The vector displayed full HIV dependency.
Conclusion: As with the earlier developed Tat-dependent expression vectors, the Rev system
described here is an exploitation of an evolved HIV process. The inclusion of Rev-dependency
renders the LTR-based expression vector highly dependent on the presence of replicating HIV. The
application of this vector as reported here, an HIV-dependent reporter virus, offers a novel
alternative approach to existing methods, in situ PCR or HIV antigen staining, to identify HIV-
positive cells. The vector permits examination of living cells, can express any gene for basic or
clinical experimentation, and as a pseudo-typed lentivirus has access to most cell types and tissues.
Background
All HIV-dependent expression vectors in common use are
based on the HIV long terminal repeat promoter (LTR).
An early HIV gene product, Tat, increases the level of tran-
script that is initiated at the LTR. The placement of
reporter genes downstream of the LTR results in a respon-
siveness to the synthesis of Tat, a measure of HIV replica-
tion. The earliest indicator lines made use of reporter
enzymes, such as luciferase and β-galactosidase [1-4], per-
mitting a direct measurement of reporter gene induction.
Tat appears to increase HIV transcriptional activity by two
mechanisms. The first identified Tat activity is not directed
towards the proviral DNA promoter, but rather through
direct association with the growing nascent RNA chain.
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Tat associates with a 5' RNA loop structure [5-7], the trans-
activation response element (TAR), to promote comple-
tion of the initiated transcript [8-10], an activity also
defined as processivity or anti-termination. More recent
work has provided evidence that Tat also stimulates
assembly of transcription factors to the DNA promoter
[11]; that is, Tat promotes initiation, as well as elongation
[12]. However, the LTR as a promoter is inherently leaky.
Following integration of the HIV DNA into the host chro-
matin, the LTR transcribes the early gene products Tat,
Rev, and Nef. That is, there is a required basal level of tran-
scription that is Tat-independent. In addition, the site of
integration or insertion of the LTR-based expression vec-
tor can mediate high levels of transcriptional activity in
some cells [13], leading to expression from the reporter
LTR in the absence of HIV. For example, in the generation
of HIV indicator cells with LTR-based reporters, it has
been necessary to remove 25% or more of the stably trans-
fected cells [4,14] since they generate reporter transcript in
the absence of HIV. While high expression cells can be
removed in the generation of reporter clones, this inher-
ent leakiness prevents the use of viral vectors to deliver the
LTR-based reporter construct to detect the presence of
existing HIV-positive cells in a mixed population.
By eliminating this non-specific activity, that is, non-HIV
induction of signal, from an HIV expression vector, a
wider use of this convenient and efficient tool would be
possible. In addition to Tat, HIV transcriptional activity is
also affected by an early gene product, Rev. Rev binds to a
3' loop structure, the Rev response element (RRE), present
in unspliced and singly-spliced HIV transcripts, to permit
nuclear export and translation of these mRNAs [15-17].
This viral specific activity exploits an essential cellular
process. The removal of non-coding regions of transcripts
(introns) prior to translation is critical to all cells. Introns
are operationally defined by the presence of strong splic-
ing sites, and HIV exploits this cellular activity by includ-
ing multiple splice sites with varying activity [18,19] to
generate multiple coding regions within the same stretch
of HIV RNA. The existence of these sites results in the gen-
eration of fully spliced transcripts in the early phase of
HIV infection [20,21]. Once Rev is expressed, RRE-con-
taining HIV transcripts can be delivered to the cytosolic
translational machinery.
It is of interest that in HIV infection protein expression
from singly or non-spliced HIV transcripts appears abso-
lutely dependent on Rev expression [15,22,23]. This
dependency is lost with seemingly minor modifications to
HIV DNAs [24,25], and the earliest reported RRE-contain-
ing expression constructs [26,27] can display varied Rev-
independent expression. These were designed to elucidate
Rev function, and the focus was not to eliminate back-
ground signal. In this report, by inclusion of multiple
components of the HIV genome, we have constructed a
lentiviral expression vector that displays a full dependency
on the presence of HIV. As it is silent in HIV-negative cells,
it differs dramatically from LTR-based systems.
Results
To test the potential of Rev from HIV infection to control
reporter gene expression in an HIV-dependent fashion, we
constructed an HIV-like vector as shown in Fig. 1. Overall,
we incorporated four separate segments of the HIV
genome into the expression vector; however, no HIV gene
is expressed from this construct. The 5' end of the vector
consists of the HIV 5' LTR, the splice donor 1 site, D1, and
a portion of the gag open reading frame that includes the
packaging signal. The second HIV segment is from the
tat1/rev1 exon that includes splice acceptor site 5, A5, and
splice donor site 4, D4. The third segment of HIV DNA is
from the env  exon and encompasses the RRE, and the
splice acceptor site 7, A7. The last segment includes the
entire 3' LTR along with a small portion of the nef reading
frame 5' to the LTR. In infectious HIV, the joining of splice
donor 1 with splice acceptor site 5 (removal of D1/A5
intron) is utilized in transcripts for both Envelope and Nef
proteins. In HIV NL4-3 infection of PBMC, the single
spliced D1/A5 transcript represents 80% of all Env mes-
sage [19]. Nef transcript requires a second splicing event,
and the most common is removal of the segment between
D4 and A7 [19]. The vector has the capacity to express two
genes. A multiple-cloning site (MCS) for one of the
expressed genes is immediately down-stream of the A5/
D4 HIV splice sites; however, this cloning site has not
been utilized in this report. This is followed by an internal
ribosome entry site (IRES), which is upstream to the
reporter gene used in this report, green fluorescent protein or
GFP. The reporter gene is adjoined to the RRE-containing
env exon segment. Together these segments compose the
transfer vector. The full-length transcript generated from
the construct possesses efficient HIV splice sites that medi-
ate the removal of the reporter open reading frame (see
Fig. 1). The reporter gene is only expressed from the RRE-
containing unspliced or singly spliced transcripts, and
thus requires the presence of Rev, a process that mimics
HIV late gene expression. Co-transfection of this plasmid
with an Env-coding plasmid and a packaging construct
results in production of an infectious non-replicative len-
tiviral vector [28] capable of transferring the Rev-depend-
ent reporter system into cells.
To permit a quantitative measurement of reporter gene
induction from the lentiviral construct in response to HIV
infection, we tested the vector in cells infected or not
infected with HIV. CEM-SS cells, a human T cell line, were
first infected with a modified, non-replicative NL4-3 HIV,
where the gene for murine CD24 was inserted into the nef
gene [29]. This NL4-3 strain possesses intact tat and revRetrovirology 2007, 4:12 http://www.retrovirology.com/content/4/1/12
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genes, but lacks an env  gene and therefore must be
pseudo-typed (see Methods). Staining of cells for murine
CD24 thus confirms the presence of HIV in a cell popula-
tion (compare lack of staining in Fig. 2A to CD24-posi-
tive, HIV-infected cells in Fig. 2B). The resultant mixed
populations of HIV-infected and non-infected CEM-SS
cells were then transduced with a predetermined titer (see
Methods) of the VSV-Env pseudo-typed Rev-dependent
indicator lentiviral vector (Fig. 2A and 2C). In Fig. 2C, in
order to determine whether a single reporter vector was
adequately robust, we added one infectious indicator vec-
tor per five cells. If we assume that the infection is a Pois-
son process, then only two percent of the cells should
contain two or more integrated indicator vectors. After 3
days, GFP was found expressed only in HIV-infected
(CD24-positive) cells (Fig. 2C); HIV-free cells transduced
with equivalent levels of indicator viral vector displayed
no GFP signal (Fig. 2A). Consistent with the viral input,
we found that approximately twenty percent of the CD24-
positive cells (HIV+) were also GFP-positive (Fig. 2C; also
Rev-dependent reporter construct Figure 1
Rev-dependent reporter construct. A. Comparison of the HIV-1 genome and the Rev-dependent vector. The vector contains 
both LTRs along with the 5' end of the gag gene, splice donors and acceptors, and a portion of the env that includes the Rev 
response element. No intact HIV genes are present. As used in this report, the lentiviral vector contains an open reading frame 
encoding green fluorescent protein (GFP). B. In the absence of HIV infection the reporter provirus undergoes basal transcrip-
tion generating a single message that is rapidly spliced, and results in the removal of the GFP reading frame. In the presence of 
HIV Rev, singly and non-spliced transcript are delivered to the cytosol, and the reporter gene is expressed.
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see legend to Fig. 2). This finding demonstrates that a sin-
gle infection of the reporter vector was adequate to detect
the presence of HIV in the cell. To examine increased dos-
age of reporter virus, we utilized a second preparation of
the lentiviral vector that had been concentrated by ultra-
centrifugation. As shown in Fig. 2D, the percent of HIV-
infected cells (CD24-positive) that expressed GFP
increased proportionally with increasing reporter viral
vector input. The curve that fits this data is a rectangular
hyperbola, defining this as a saturable process, and pre-
dicts that a maximum of 80–90% of the HIV-infected cells
examined can be labeled by the Rev-dependent reporter
virus (see legend Fig. 2 and Discussion).
Lentiviral vectors possess the capacity to infect differenti-
ated macrophages, a known target cell for in vivo HIV rep-
lication. However, regulation of HIV LTR transcriptional
activity in macrophages, compared to T cells, involves a
different set of cellular factors [30,31]. We thus examined
the capacity of the lentiviral expression vector to respond
to HIV infection of macrophages. Human primary mono-
cyte-derived macrophages were first infected with the
CCR5-utilizing HIV-1AD8 followed 24 hours later by addi-
tion of the reporter lentiviral vector under conditions sim-
ilar to the above CEM cell experiment. After 5 days the
cells were fixed and stained for the presence of intracellu-
lar HIV p24 (Fig. 3). HIV-infected macrophages, stained
for anti-p24, display cytosolic, perinuclear areas of high
intensity due to accumulated viral particles, along with
formation of large cells [32,33]. High intensity focal stain-
ing with anti-p24 (red fluorescence) was seen in multiple
cells (see Fig. 3B, cells 1–9). Staining of cells in non-
infected control populations was absent for both anti-p24
and GFP (data not shown), and GFP was expressed only
in cells that were p24-positive (compare Fig. 3B and 3C).
Of 308 cells examined here, 97 were p24-positive, and 22
of these were also GFP-positive. Under the conditions
used in this experiment, and consistent with the viral
input, approximately one fifth of the p24-positive macro-
phages displayed GFP production. As with the CEM exper-
iment (Fig. 2), this finding suggests that a single infecting
indicator viral vector in macrophages is capable of report-
ing the presence of HIV.
The Rev-dependent system outlined in Fig. 1 operates
under the assumption that in the absence of HIV there is
elimination, through splicing, of GFP-encoding tran-
script. Upon Rev expression, the non-spliced RRE-con-
taining GFP transcript would be rescued. To test this
hypothesis, we performed RT-PCR on control and HIV-
infected CEM-SS cells that were secondarily exposed to the
reporter GFP-encoding viral vector at high input levels
(see Fig. 4 legend). High levels of reporter vector were
used to challenge the cell's capacity to remove GFP-encod-
ing non-spliced transcript in the absence of HIV, that is, to
remove false-positive reporter message. We used two sets
of primers that amplified the spliced or non-spliced tran-
scripts from the lentiviral construct (Fig. 4A), and com-
pared spliced to unspliced reporter transcript in four cell
populations: uninfected cells, cells infected with HIV
only, cells infected with reporter virus only, and cells
infected with both virus. Note that the vectors used to
detect spliced transcript will also recognize HIV tran-
scripts. As shown in Fig. 4B, HIV-specific transcript, con-
sistent with the size of fully spliced transcript amplified
with these primers (0.94 kb), appeared in the two cell
populations infected with HIV (lanes 2 and 4). In cells
exposed to the reporter vector but lacking HIV, we
observed basal levels of transcription from the LTR pro-
moter of the reporter vector (lane 3). This transcriptional
activity represents HIV-independent LTR-mediated signal
(the leakiness seen with LTR-based systems); however,
with this Rev-dependent system the transcripts were all
spliced (lane 3; spliced RNA vs unspliced RNA) and thus
lacked the capacity to generate the GFP reporter. Follow-
ing exposure to the reporter viral vector, the generation of
a non-spliced, reporter-encoding message (seen in lane 4)
was dependent on the presence of HIV infection. These
data confirmed that expression of GFP-encoding tran-
script was HIV-dependent, and that the dependency corre-
sponded to the prevention of transcript splicing,
consistent with Rev activity.
Discussion
The Rev-dependent expression vector displayed highly
specific HIV-dependent expression. The application tested
here, as a lentiviral reporter for HIV detection, permitted
us to address two major concerns: non-specific (HIV-inde-
pendent) noise and inadequate specific (HIV-dependent)
signal. The first concern is based on knowledge that
expression from an integrated LTR vector can be affected
by the local chromatin activity, resulting in HIV- or Tat-
independent high expression [13]. Of course, this is what
prevents utilization of LTR-based reporter viruses. With
the establishment of LTR-based indicator cells, it's just a
matter of removing cells with aberrantly high background
reporter expression [4,14]. This problem appeared to be
absent in cells transduced with the Rev-dependent vector
system, since expression of GFP in both a T cell line and a
primary macrophage population occurred only in HIV-
positive cells. Furthermore, we found that GFP-encoding
transcript was detected by RT-PCR only in HIV-infected
populations. Secondly, we wished to know whether this
vector, potentially as a single integrant and with the added
stringency of Rev-dependence, would generate an ade-
quately robust response. To address this point we exam-
ined reporter function under conditions that maximized
single reporter integrants. It does assume that infections
follow a Poisson function, a central tenet to most virus
infection studies. At an input where 80% of the cells doRetrovirology 2007, 4:12 http://www.retrovirology.com/content/4/1/12
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Specific expression of reporter by the Rev-dependent lentivirus in HIV infected T cells Figure 2
Specific expression of reporter by the Rev-dependent lentivirus in HIV infected T cells. CEM-SS cells were not infected (A) or 
were infected (B, C) with HIV-1 NL4-3.HSA.R+E-, an HIV-1 NL4-3 clone with the murine heat stable antigen (HSA; CD24) 
gene inserted into the nef gene. Both uninfected (A) and infected (C) cells were then transduced with the Rev-dependent 
reporter virus vNL-GFP-RRE(SA) (5 ng p24/106 cells; VSV-G envelope) or not transduced (B). At 72 hrs post transduction, 
cells were stained with R-phycoerythrin conjugated rat-anti-mouse CD24 antibody and analyzed by flow cytometer for CD24 
and GPF expression. GFP was expressed only in HIV-1 infected (C), but not in HIV-1 uninfected (A) cells. Fifty thousand cells 
were examined in each run. In this run 61% of total cells were CD24-positive and of the CD24-positive population 17% were 
GFP-positive. Thresholds for CD24-positive and GFP-positive were set at a fluorescent intensity of 10 on the x- and y-axis 
respectively. Two independent analyses yielded the same result. D. Percent HIV-infected cells that express GFP versus 
reporter vector input. A concentrated preparation of reporter particles was used at varied dosages in HIV-infected CEM cells, 
as above. Flow cytometry studies yielded percent CD24-positive cells that became GFP-positive after 3 days (y-axis) versus 
reporter virus input (ng p24). Non-linear curve fitting (rectangular hyperbola) yielded R2 = 99.4; maximum GFP-positive = 86.1 
± 6.3% (best-fit values ± std. error); KD = 128.1 ± 21.5 ng p24. Dashed lines are 95% confidence bands.
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not become infected (approximately one infectious parti-
cle per five cells), less than 2% of the cells should possess
more than one reporter provirus. Expression of GFP
reporter from the HIV-positive cells closely approximated
the input reporter viral vector level (Fig. 2 and 3), suggest-
ing that undetected expression of integrated vectors is not
prominent. Note, however, that expression of the reporter
gene is achieved in cells that are also highly supportive of
transcriptional activity from the HIV provirus, that is, LTR
activity is supported. Both HIV and the reporter vector use
the LTR promoter.
We also examined high doses of reporter viral vector,
where a majority of the cells are infected with the Rev-
dependent reporter vector. Under these conditions we did
not see intact reporter (unspliced) transcript or protein in
HIV-negative cells. The nature of the curve that fits the
reporter vector detection of HIV-infected cells (Fig. 2D)
suggests that the rate-limiting step towards reporter
expression follows Michaelis-Menten kinetics. This is
characteristic of a single binding-site event, but at this
time we are unable to define this rate-limiting process,
such as the viral particle binding to the cellular receptor.
Additional mechanisms leading to this non-linear func-
tion would include the potentially equivalent susceptibil-
ity of increasing numbers of infected cells to additional
infection, as characterized by a Poisson distribution. Con-
centration of this viral particle by centrifugation permitted
this examination of high vector input, but it also dimin-
ished the infectivity of the viral particles. This data also
predicts that most of the HIV-infected cells will be suscep-
tible to detection by the reporter virus. Of course, in
mixed cell populations or tissues there will be variable
susceptibilities to infection by the reporter virus as pres-
ently used. The inability to infect all cells by the reporter
virus is perhaps the most limiting aspect of this applica-
tion of the Rev-dependent vector.
In this report we have utilized the term Rev-dependence to
distinguish this construct from the existing LTR-based Tat-
responsive HIV reporter systems; however, with the intact
LTR, we would speculate that this Rev-dependent vector
should maintain responsiveness to Tat expression as well.
This dual dependency is likely to contribute to the higher
stringency seen. In this document, we have characterized
this Rev-dependent vector in only one application (viral
reporter vector), an application that is challenging and
not feasible with the LTR-based reporters. At the same
time we view this application as supplementary to existing
methods to test cells for the presence of HIV replication.
These include the staining or probing of HIV proteins and
nucleic acids in fixed cells, and may include amplification
with PCR [34-36]. We have also incorporated the vector
into continuous cell lines (data not shown). As intro-
Specific expression of reporter by the Rev-dependent lentiviral vector in HIV-infected primary macrophages Figure 3
Specific expression of reporter by the Rev-dependent lentiviral vector in HIV-infected primary macrophages. M-CSF-treated 
monocyte-derived macrophages were infected or were not infected with HIVAD8, followed by Rev-dependent reporter virus 
vNL-GFP-RRE(SA). (A). Bright-field image of fixed cells with black bar representing 50 micrometers. Nuclei are prominent. 
Cells that were found to stain positive for HIV p24 are numbered in this image. B. Red fluorescence of identical field. All cells 
were stained for anti-p24 antibody, followed by a secondary red fluorescent antibody to detect productively infected cells. 
Intracellular red fluorescent foci identify productive infection; nine cells were identified in this field (B). We examined macro-
phage populations with four concentrations of HIV input (36, 72, 169, and 361 ng p24 HIVAD8/106 cells) followed by a constant 
input of reporter lentiviral vector (5 ng p24 vNL-GFP-RRE(SA)/106 cells; VSV-G envelope). Independent of the input of HIV, 
approximately one fifth of the p24-positive cells expressed GFP (23.0 ± 2.8%; mean ± SD; n = 4), as shown by green fluores-
cence in this same field (C). Magnification was identical on all three images. The reporter virus was demonstrated to function in 
macrophages from three donors.Retrovirology 2007, 4:12 http://www.retrovirology.com/content/4/1/12
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duced into a transformed T cell, we find that expression
from this Rev-dependent vector is insensitive to cellular
activation states, thus maintaining a negative background
in the absence of HIV, but has enhanced sensitivity to HIV
infection, relative to many of the existing non-T cell indi-
cator cell lines. Although this report has been limited to
the expression of reporter genes, the construct's incorpo-
ration into a lentivirus and the specificity acquired should
also permit its use as an experimental agent to express any
gene in HIV-infected cells.
Conclusion
The inclusion of Rev-dependent processing to an LTR-
based vector has resulted in a highly specific HIV-depend-
ent expression system.
Methods
Viruses and cells
Viruses and cells were obtained through the NIH AIDS
Research and Reference Reagent Program: pNL4-
3.HSA.R+E- from Dr. Nathaniel Landau [29]; CEM-SS
from Dr. Peter L. Nara [37]; J1.1 cells from Dr. Thomas
Folks [38]. HIV-1AD8 is a macrophage-tropic molecular
clone [39]. Macrophages were derived from peripheral
blood monocytes of healthy donors from the Department
of Transfusion Medicine at the National Institutes of
Health. Cells were cultured in RPMI media supplemented
with 10% fetal bovine serum (Hyclone) and recombinant
human macrophage colony stimulating factor (rH-MCSF)
(R & D Systems) at 10 ng/ml. Media was changed every 48
hours for ten days.
DNA constructs
pCMV∆R8.2 and pMD.G have been described previously
[28]. pNL-GFP-RRE was constructed by complete deletion
of all HIV ORFs of pNL4-3 [40] by replacing the 8.1 kb
BssHII-BlpI fragment of the HIV-1 genomes with an insert
containing the GFP ORF and the HIV-1 Rev-responsive
element (RRE) including the HIV-1 sequence immediately
following the BssHII site and the first 336 nucleotides of
the gag ORF (the gag reading frame was disrupted by a
frame shift mutation at the ClaI site by blunt end liga-
tion), the GFP ORF was derived from pIRES-hrGFP-1a
(Stratagene) by PCR amplification (5' CTCGAAATTAAC-
CCTCACTAAAGG 3'; 5'ATCGTGTACGGCCGAATTGGGT-
ACACTTACCTG 3'), and the fragment containing RRE
(corresponding to position 7612 to 8469 of the HIV-
1NL4-3 genome). pNL-GFP-RRE-(SA) was constructed by
insertion of a PCR fragment into the NotI-SmaI site of
pNL-GFP-RRE, in front of the GFP ORF. The insert carry-
ing the HIV-1 A5 splicing acceptor and D4 donor was
amplified by primers: 5' ATAAGAATGCGGCCGCATCTC-
CTATGGCAGGAAG 3'; 5' AATCACCCGGGTGCTAC-
TACTAATGCTACTATTGC 3'. The sequence of pNL-GFP-
RRE-(SA) has been deposited in GenBank (accession
number EF408805).
Virus generation
Stocks of the HIV-1NL4-3 and HIV-1AD8 were prepared by
transfection of HeLa cells with cloned proviral DNA. HIV-
1 based lentiviral vectors carrying reporter genes were
made by cotransfection of DNA constructs as follows: 2 ×
106 293T cells were cotransfected with 10 ug of pNL-GFP-
RRE-SA, 7.5 ug of pCMV∆R8.2, and 2.5 ug of pMD.G
using the calcium phosphate method (Promega). Viral
particles were harvested 2 days after cotransfection and fil-
Reverse transcriptase PCR analyses of gene expression from  lentiviral vector NL-GFP-RRE-(SA) in response to HIV-1  infection Figure 4
Reverse transcriptase PCR analyses of gene expression from 
lentiviral vector NL-GFP-RRE-(SA) in response to HIV-1 
infection. (A) A diagram of PCR primers used. Two sets of 
primers were used to detect the spliced (black arrows) and 
unspliced (green arrows) transcripts by reverse transcriptase 
PCR (RT-PCR) as described in Methods. The mRNA mole-
cules from infected and uninfected cells were extracted at 
day 3 after lentiviral vector infection and analyzed by RT-PCR 
for the spliced transcripts and unspliced transcripts as shown 
in (B). (B) CEM-SS cells were either uninfected (lane 1, con-
trol), infected with HIV alone (lane 2, HIV, VSV-G pseudo-
typed, 564 ng p24 per million cells), infected with NL-GFP-
RRE-(SA) alone (lane 3, 1764 ng p24 virion per million cells), 
or infected with HIV first, then NL-GPF-RRE(SA) 24 hours 
later (lane 4). The cellular β-actin transcript was also ampli-
fied to ensure that comparable numbers of cells were used 
for the analyses.
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tered through a 0.45 um filter and stored at -80°. One
preparation was concentrated by ultracentrifugation [41].
The titer (TCID50) of the lentiviral indicator vNL-GFP-
RRE(SA) virus preparation was estimated by serial dilu-
tion into activated (TNF-treated) HIV-positive J1.1 Jurkat
cells [38] following the method of Reed and Muench [42].
RT-PCR analysis
Total cellular poly(A+) mRNA was purified from cells by
MicroPoly(A)Pure mRNA isolation kit (Ambion) as rec-
ommended by the manufacturer. Reverse transcription
was accomplished using the RETROscript First-Strand
Synthesis Kit (Ambion) with random decamers as the
first-strand primers. Following cDNA synthesis, PCR was
carried out using primer
5'TAATCGGCCGAACAGGGACTTGAAAGCGAAAG3' and
5'CAGGCACAAGCAGCATTGTTAG 3' to amplify spliced
lentiviral transcripts, and primer 5'
TAATCGGCCGAACAGGGACTTGAAAGCGAAAG3' and
5'ATCGTGTACGGCCGAATTGGGTACACTTACCTG3' to
amplify non-spliced GFP transcripts. The PCR condition
was: 1 × PCR buffer, 125 uM dNTPs, 1.5 mM Mg2+, 50
pmol of each primer, 1 U SuperTaq Plus (Ambion) in 50
ul, with 30 cycles of 20 sec at 94°, and 180 sec at 68°. One
fifth of the product was analyzed on 2% agarose gel. Cel-
lular β-actin transcripts were amplified using Quantum-
RNA β-actin Internal Standards (Ambion) with similar
conditions as above except using 20 pmol of each actin
primer and runs at 20 sec at 94°, 30 sec at 55°, and 40 sec
at 68°.
Reporter virus detection of HIV infection
CEM-SS cells, infected with VSV pseudo-typed HIV-1 NL4-
3.HSA.R+E- [29], were enriched by biotin conjugated rat-
anti-mouse CD24 antibody and streptavidin conjugated
magnetic beads and further cultured for two weeks to
remove the beads. The enriched population was then
infected with the Rev-dependent lentiviral vector, vNL-
GFP-RRE(SA). At 72 hrs post transduction, cells were
stained with R-phycoerythrin conjugated rat-anti-mouse
CD24 antibody and analyzed by flow cytometer for CD24
and GPF expression. Curve fitting and statistical analysis
were achieved with GraphPad Prism software.
Monocyte-derived macrophages in six well plates were
infected with HIVAD8 (36 to 360 ng p24) in 500 ul of RPMI
for 3 hours, then washed and returned to 2 ml RPMI. The
following day, 5 ng p24 of pNL-GFP-RRE(SA) was applied
to the macrophages. At 5 days post infection, cells were
intracellularly stained on ice. Briefly, cells were rinsed
once with Hank's buffer followed by treatment with
Cytofix/Cytoperm (Becton Dickinson) for 20 min, then 2
ml of cold methanol for 15 min. After washing with Per-
meabilization/Wash buffer (Becton Dickinson), cells were
stained with anti-p24 HIV antibody 183.H12-5C (1:250)
[43-45] for 90 min, followed by washing and staining
with Alexa Fluor-568 goat anti-mouse IgG (Invitrogen)
(1:250) for 30 minutes.
Fluorescent microscopy of monocyte-derived 
macrophages
The GFP-expressing and anti-p24 stained cells were pho-
tographed using a Leica DMIRB/E inverted research
microscope attached to a Orca DCAM ER camera
(Hamamtsu), using an XF102.2 filter (Omega Optical
Inc.) for the Alexa Fluor-568 (p24) detection and a GFP
filter (Leica) for the GFP expressing cells. P24 expression
and GFP expression were captured with similar exposures,
typically 1000 milliseconds. Files were saved as Tiffs and
color was added on ImageJ software version 1.33u (Ras-
band, W., NIH-public domain). Dimensions were deter-
mined through a stage micrometer (Electron Microscopy
Sciences).
Flow cytometry
Infected or uninfected cells were re-suspended into 100 ul
Hank's staining buffer (Hank's buffer plus 0.1% bovine
serum albumin, 0.1% sodium azide, and 25 mM HEPES,
pH 7.2) for staining with antibodies at concentrations rec-
ommended by manufactures. Following staining for 30
min on ice, cells were either washed with Hank's buffer or,
in the case of HIV-infected cells, fixed with 500 ul of
Cytofix/Cytoperm (Becton Dickenson) for 20 min on ice
for flow cytometry analysis on a FACScan analyzer (Bec-
ton Dickenson). The murine CD24 antibody was from
Southern Biotechnology.
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